<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01//EN" "http://www.w3.org/TR/html4/strict.dtd">
<html xmlns:n1="urn:hl7-org:v3" xmlns:in="urn:lantana-com:inline-variable-data" xmlns:sdtc="urn:hl7-org:sdtc"><head>
<meta charset="utf-8"><!-- Do NOT edit this HTML directly: it was generated via an XSLT transformation from a CDA Release 2 XML document. --><title>Patient Health Record</title><style type="text/css">
body {
  color: #003366;
  background-color: #FFFFFF;
  font-family: Verdana, Tahoma, sans-serif;
  font-size: 14px;
}

a {
  color: #003366;
  background-color: #FFFFFF;
}

h1 {
  font-size: 20px;
  font-weight: bold;
}

h2 {
  font-size: 18px;
  font-weight: bold;
}

h3 {
  font-size: 14px;
  font-weight: bold;
}

h4 {
  font-size: 14px;
  font-weight: bold;
}


table {
  width: 100%;
}

th {
  background-color: #ffd700;
}

td {
  padding: 0.1cm 0.2cm;
  vertical-align: top;
  background-color: #ffffcc;
}

.h1center {
  font-size: 20px;
  font-weight: bold;
  text-align: center;
  width: 80%;
}

.header_table{
  border: 1pt inset #00008b;
}

.td_label{
  font-weight: bold;
  color: white;
}

.content_span{
 font-family: Verdana, Tahoma, sans-serif;
 display: inline;
 white-space: pre-line;
}

.td_header_role_name{
  width: 20%;
  background-color: #3399ff;
}

.td_header_role_value{
  width: 80%;
  background-color: #ccccff;
}

.Bold{
  font-weight: bold;
}

.Italics{
  font-style: italic;
}

.Underline{
  text-decoration:underline;
}

.internal_format
{
	list-style: none;
	list-style-position:outside;
	margin:0;
	padding:0;
	border:0;
	border-collapse: collapse;
}
          </style></head><body>
<h2><a name="toc">Table of Contents</a></h2><ul><li><a href="#id1">Allergies</a></li><li><a href="#id2">Results</a></li><li><a href="#id3">Reason For Referral</a></li><li><a href="#id4">Medications</a></li><li><a href="#id5">Immunizations</a></li><li><a href="#id6">Social History</a></li><li><a href="#id7">Problems</a></li><li><a href="#id8">Vital Signs</a></li><li><a href="#id9">Procedures</a></li><li><a href="#id10">Encounters</a></li><li><a href="#id11">Medical Equipment</a></li><li><a href="#id12">Assessments</a></li><li><a href="#id13">Plan Of Treatment</a></li><li><a href="#id14">Goals Section</a></li><li><a href="#id15">Health Concerns</a></li><li><a href="#id16">Insurance Providers</a></li><li><a href="#id17">Medical (General) History</a></li></ul><hr align="left" color="teal" size="2"/><h3><a name="id1" href="#toc">Allergies</a></h3><div><table width="100%" border="1"><thead><tr><th>Allergen (clinical drug ingredient)</th><th>Drug/Non Drug Allergy documented on EMR</th><th>Reaction</th><th>Allergy Type</th><th>Onset Date</th><th>Status</th></tr></thead><tbody><tr><td ID="allergy1">tramadol</td><td>Tramadol</td><td ID="reaction1">Unknown</td><td>Drug Allergy</td><td/><td>Active</td></tr></tbody></table></div><h3><a name="id2" href="#toc">Results</a></h3><div><table width="100%" border="1"><thead><tr><th>Component</th><th>Value</th><th>Reference Range</th><th>Notes</th></tr></thead><tbody><tr><td colspan="4"><span class="content_span">LIPID PANEL, STANDARD (7600)</span><br/>Reviewed date:[REDACTED] 10:15:22 AM<br/>Interpretation:<br/>Performing Lab:TP, Quest Diagnostics-[REDACTED]
[REDACTED][REDACTED][REDACTED] [REDACTED] MD<br/>Notes/Report:<br/>FASTING:YES<br/>FASTING: YES</td></tr><tr><td ID="result1_attr1">CHOLESTEROL, TOTAL</td><td>156</td><td>&lt;200 mg/dL</td><td/></tr><tr><td ID="result1_attr2">HDL CHOLESTEROL</td><td>65</td><td>&gt; OR = 50 mg/dL</td><td/></tr><tr><td ID="result1_attr3">TRIGLYCERIDES</td><td>99</td><td>&lt;150 mg/dL</td><td/></tr><tr><td ID="result1_attr4">LDL-CHOLESTEROL</td><td>73</td><td/><td ID="result1_attr4_notes"><p>Reference range: &lt;100</p><p>Desirable range &lt;100 mg/dL for primary prevention;</p><p>&lt;70 mg/dL for patients with CHD or diabetic patients</p><p>with &gt; or = 2 CHD risk factors.</p><p>LDL-C is now calculated using the [REDACTED]</p><p>calculation, which is a validated novel method providing</p><p>better accuracy than the Friedewald equation in the</p><p>estimation of LDL-C.</p><p>[REDACTED] et al. JAMA. 2013;310(19): [REDACTED]-[REDACTED]</p><p>(http://education.QuestDiagnostics.com/faq/FAQ164)</p></td></tr><tr><td ID="result1_attr5">CHOL/HDLC RATIO</td><td>2.4</td><td>&lt;5.0 (calc)</td><td/></tr><tr><td ID="result1_attr6">NON HDL CHOLESTEROL</td><td>91</td><td>&lt;130 mg/dL (calc)</td><td ID="result1_attr6_notes"><p>For patients with diabetes plus 1 major ASCVD risk</p><p>factor, treating to a non-HDL-C goal of &lt;100 mg/dL</p><p>(LDL-C of &lt;70 mg/dL) is considered a therapeutic</p><p>option.</p></td></tr><tr><td colspan="4"><span class="content_span">COMPREHENSIVE METABOLIC PANEL (10231)</span><br/>Reviewed date:[REDACTED] 10:15:13 AM<br/>Interpretation:<br/>Performing Lab:TP, Quest Diagnostics-[REDACTED]
[REDACTED][REDACTED][REDACTED] [REDACTED] MD<br/>Notes/Report:<br/>FASTING: YES<br/>FASTING:YES</td></tr><tr><td ID="result2_attr1">GLUCOSE</td><td>101</td><td>65-99 mg/dL</td><td ID="result2_attr1_notes"><p>           Fasting reference interval</p><p>For someone without known diabetes, a glucose value</p><p>between 100 and 125 mg/dL is consistent with</p><p>prediabetes and should be confirmed with a</p><p>follow-up test.</p></td></tr><tr><td ID="result2_attr2">UREA NITROGEN (BUN)</td><td>17</td><td>7-25 mg/dL</td><td/></tr><tr><td ID="result2_attr3">CREATININE</td><td>0.76</td><td>0.60-1.00 mg/dL</td><td/></tr><tr><td ID="result2_attr4">EGFR</td><td>83</td><td>&gt; OR = 60 mL/min/1.73m2</td><td/></tr><tr><td ID="result2_attr5">BUN/CREATININE RATIO</td><td>SEE NOTE:</td><td>6-22 (calc)</td><td ID="result2_attr5_notes"><p>   Not Reported: BUN and Creatinine are within</p><p>   reference range.</p></td></tr><tr><td ID="result2_attr6">SODIUM</td><td>136</td><td>135-146 mmol/L</td><td/></tr><tr><td ID="result2_attr7">POTASSIUM</td><td>4.3</td><td>3.5-5.3 mmol/L</td><td/></tr><tr><td ID="result2_attr8">CHLORIDE</td><td>96</td><td>98-110 mmol/L</td><td/></tr><tr><td ID="result2_attr9">CARBON DIOXIDE</td><td>30</td><td>20-32 mmol/L</td><td/></tr><tr><td ID="result2_attr10">CALCIUM</td><td>10.3</td><td>8.6-10.4 mg/dL</td><td/></tr><tr><td ID="result2_attr11">PROTEIN, TOTAL</td><td>7.0</td><td>6.1-8.1 g/dL</td><td/></tr><tr><td ID="result2_attr12">ALBUMIN</td><td>4.7</td><td>3.6-5.1 g/dL</td><td/></tr><tr><td ID="result2_attr13">GLOBULIN</td><td>2.3</td><td>1.9-3.7 g/dL (calc)</td><td/></tr><tr><td ID="result2_attr14">ALBUMIN/GLOBULIN RATIO</td><td>2.0</td><td>1.0-2.5 (calc)</td><td/></tr><tr><td ID="result2_attr15">BILIRUBIN, TOTAL</td><td>0.7</td><td>0.2-1.2 mg/dL</td><td/></tr><tr><td ID="result2_attr16">ALKALINE PHOSPHATASE</td><td>45</td><td>37-153 U/L</td><td/></tr><tr><td ID="result2_attr17">AST</td><td>21</td><td>10-35 U/L</td><td/></tr><tr><td ID="result2_attr18">ALT</td><td>27</td><td>6-29 U/L</td><td/></tr><tr><td colspan="4"><span class="content_span">CBC (INCLUDES DIFF/PLT) (6399)</span><br/>Reviewed date:[REDACTED] 10:14:58 AM<br/>Interpretation:<br/>Performing Lab:TP, Quest Diagnostics-[REDACTED]
[REDACTED][REDACTED][REDACTED] [REDACTED] MD<br/>Notes/Report:<br/>FASTING:YES<br/>FASTING: YES</td></tr><tr><td ID="result3_attr1">WHITE BLOOD CELL COUNT</td><td>7.0</td><td>3.8-10.8 Thousand/uL</td><td/></tr><tr><td ID="result3_attr2">RED BLOOD CELL COUNT</td><td>4.64</td><td>3.80-5.10 Million/uL</td><td/></tr><tr><td ID="result3_attr3">HEMOGLOBIN</td><td>14.1</td><td>11.7-15.5 g/dL</td><td/></tr><tr><td ID="result3_attr4">HEMATOCRIT</td><td>43.2</td><td>35.0-45.0 %</td><td/></tr><tr><td ID="result3_attr5">MCV</td><td>93.1</td><td>80.0-100.0 fL</td><td/></tr><tr><td ID="result3_attr6">MCH</td><td>30.4</td><td>27.0-33.0 pg</td><td/></tr><tr><td ID="result3_attr7">MCHC</td><td>32.6</td><td>32.0-36.0 g/dL</td><td/></tr><tr><td ID="result3_attr8">RDW</td><td>13.2</td><td>11.0-15.0 %</td><td/></tr><tr><td ID="result3_attr9">PLATELET COUNT</td><td>345</td><td>140-400 Thousand/uL</td><td/></tr><tr><td ID="result3_attr10">MPV</td><td>8.8</td><td>7.5-12.5 fL</td><td/></tr><tr><td ID="result3_attr11">ABSOLUTE NEUTROPHILS</td><td>5075</td><td>1500-7800 cells/uL</td><td/></tr><tr><td ID="result3_attr12">ABSOLUTE LYMPHOCYTES</td><td>1183</td><td>850-3900 cells/uL</td><td/></tr><tr><td ID="result3_attr13">ABSOLUTE MONOCYTES</td><td>630</td><td>200-950 cells/uL</td><td/></tr><tr><td ID="result3_attr14">ABSOLUTE EOSINOPHILS</td><td>70</td><td>15-500 cells/uL</td><td/></tr><tr><td ID="result3_attr15">ABSOLUTE BASOPHILS</td><td>42</td><td>0-200 cells/uL</td><td/></tr><tr><td ID="result3_attr16">NEUTROPHILS</td><td>72.5</td><td/><td/></tr><tr><td ID="result3_attr17">LYMPHOCYTES</td><td>16.9</td><td/><td/></tr><tr><td ID="result3_attr18">MONOCYTES</td><td>9.0</td><td/><td/></tr><tr><td ID="result3_attr19">EOSINOPHILS</td><td>1.0</td><td/><td/></tr><tr><td ID="result3_attr20">BASOPHILS</td><td>0.6</td><td/><td/></tr><tr><td ID="result3_attr21">COMMENT</td><td/><td/><td ID="result3_attr21_notes"><p/><p>We received your handwritten test order and performed</p><p>CBC with differential (includes hemogram, platelet</p><p>count and WBC with automated differential). If you</p><p>intended to order a CBC without differential or</p><p>another test, please contact us at [REDACTED]</p><p>([REDACTED]), to adjust the billing</p><p>appropriately.</p></td></tr><tr><td colspan="4"><span class="content_span">HEMOGLOBIN A1c (496)</span><br/>Reviewed date:[REDACTED] 10:15:05 AM<br/>Interpretation:<br/>Performing Lab:TP, Quest Diagnostics-[REDACTED]
[REDACTED][REDACTED][REDACTED][REDACTED]<br/>Notes/Report:<br/>FASTING:YES<br/>FASTING: YES</td></tr><tr><td ID="result4_attr1">HEMOGLOBIN A1c</td><td>5.7</td><td>&lt;5.7 % of total Hgb</td><td ID="result4_attr1_notes"><p>For someone without known diabetes, a hemoglobin</p><p>A1c value between 5.7% and 6.4% is consistent with</p><p>prediabetes and should be confirmed with a</p><p>follow-up test.</p><p>For someone with known diabetes, a value &lt;7%</p><p>indicates that their diabetes is well controlled. A1c</p><p>targets should be individualized based on duration of</p><p>diabetes, age, comorbid conditions, and other</p><p>considerations.</p><p>This assay result is consistent with an increased risk</p><p>of diabetes.</p><p>Currently, no consensus exists regarding use of</p><p>hemoglobin A1c for diagnosis of diabetes for children.</p><p>This test was performed on the Roche cobas c503 platform.</p><p>Effective [REDACTED], a change in test platforms from the</p><p>[REDACTED] Architect to the Roche cobas c503 may have shifted</p><p>HbA1c results compared to historical results.</p><p>Based on laboratory validation testing conducted at</p><p>Quest, the Roche platform relative to the [REDACTED]</p><p>platform had an average increase in HbA1c value of</p><p>&lt; or = 0.3%. This difference is within accepted</p><p>variability established by the National Glycohemoglobin</p><p>Standardization Program. Note that not all individuals</p><p>will have had a shift in their results and direct</p><p>comparisons between historical and current results for</p><p>testing conducted on different platforms is not</p><p>recommended.</p></td></tr><tr><td colspan="4"><span class="content_span">VITAMIN D, 1,25 DIHYDROXY (16558)</span><br/>Reviewed date:[REDACTED] 08:01:01 AM<br/>Interpretation:<br/>Performing Lab:AMD, Quest Diagnostics/[REDACTED] Chantilly-Chantilly VA
[REDACTED][REDACTED] [REDACTED] M.D.,PhD<br/>Notes/Report:<br/>FASTING:YES<br/>FASTING: YES</td></tr><tr><td ID="result5_attr1">VITAMIN D, 1,25 (OH)2, TOTAL</td><td>36</td><td>18-72 pg/mL</td><td/></tr><tr><td ID="result5_attr2">VITAMIN D3, 1,25 (OH)2</td><td>36</td><td/><td/></tr><tr><td ID="result5_attr3">VITAMIN D2, 1,25 (OH)2</td><td>&lt;8</td><td/><td ID="result5_attr3_notes"><p/><p>Vitamin D3, 1,25(OH)2 indicates both endogenous</p><p>production and supplementation. Vitamin D2, 1,25(OH)2</p><p>is an indicator of exogenous sources, such as diet or</p><p>supplementation.  Interpretation and therapy are based</p><p>on measurement of Vitamin D,1,25(OH)2, Total.</p><p>This test was developed and its analytical</p><p>performance characteristics have been determined</p><p>by Quest Diagnostics [REDACTED] Institute, Chantilly, VA.</p><p>It has not been cleared or approved by the FDA. This</p><p>assay has been validated pursuant to the CLIA</p><p>regulations and is used for clinical purposes.</p></td></tr><tr><td colspan="4"><span class="content_span">VITAMIN B12/FOLATE, SERUM PANEL (7065)</span><br/>Reviewed date:[REDACTED] 08:01:01 AM<br/>Interpretation:<br/>Performing Lab:TP, Quest Diagnostics-Tampa
[REDACTED][REDACTED][REDACTED] [REDACTED] MD<br/>Notes/Report:<br/>FASTING:YES<br/>FASTING: YES</td></tr><tr><td ID="result6_attr1">VITAMIN B12</td><td>527</td><td>200-1100 pg/mL</td><td/></tr><tr><td ID="result6_attr2">FOLATE, SERUM</td><td>&gt;24.0</td><td/><td ID="result6_attr2_notes"><p>                           Reference Range</p><p>                           Low:           &lt;3.4</p><p>                           Borderline:    3.4-5.4</p><p>                           Normal:        &gt;5.4</p></td></tr><tr><td colspan="4"><span class="content_span">URINALYSIS, COMPLETE (5463)</span><br/>Reviewed date:[REDACTED] 08:01:01 AM<br/>Interpretation:<br/>Performing Lab:TP, Quest Diagnostics-[REDACTED]
[REDACTED][REDACTED][REDACTED][REDACTED]<br/>Notes/Report:<br/>FASTING:YES<br/>FASTING: YES</td></tr><tr><td ID="result7_attr1">COLOR</td><td>YELLOW</td><td>YELLOW</td><td/></tr><tr><td ID="result7_attr2">APPEARANCE</td><td>CLEAR</td><td>CLEAR</td><td/></tr><tr><td ID="result7_attr3">SPECIFIC GRAVITY</td><td>1.007</td><td>1.001-1.035</td><td/></tr><tr><td ID="result7_attr4">PH</td><td>6.0</td><td>5.0-8.0</td><td/></tr><tr><td ID="result7_attr5">GLUCOSE</td><td>NEGATIVE</td><td>NEGATIVE</td><td/></tr><tr><td ID="result7_attr6">BILIRUBIN</td><td>NEGATIVE</td><td>NEGATIVE</td><td/></tr><tr><td ID="result7_attr7">KETONES</td><td>NEGATIVE</td><td>NEGATIVE</td><td/></tr><tr><td ID="result7_attr8">OCCULT BLOOD</td><td>NEGATIVE</td><td>NEGATIVE</td><td/></tr><tr><td ID="result7_attr9">PROTEIN</td><td>NEGATIVE</td><td>NEGATIVE</td><td/></tr><tr><td ID="result7_attr10">NITRITE</td><td>NEGATIVE</td><td>NEGATIVE</td><td/></tr><tr><td ID="result7_attr11">LEUKOCYTE ESTERASE</td><td>NEGATIVE</td><td>NEGATIVE</td><td/></tr><tr><td ID="result7_attr12">WBC</td><td>NONE SEEN</td><td>&lt; OR = 5 /HPF</td><td/></tr><tr><td ID="result7_attr13">RBC</td><td>NONE SEEN</td><td>&lt; OR = 2 /HPF</td><td/></tr><tr><td ID="result7_attr14">SQUAMOUS EPITHELIAL CELLS</td><td>NONE SEEN</td><td>&lt; OR = 5 /HPF</td><td/></tr><tr><td ID="result7_attr15">BACTERIA</td><td>NONE SEEN</td><td>NONE SEEN /HPF</td><td/></tr><tr><td ID="result7_attr16">HYALINE CAST</td><td>NONE SEEN</td><td>NONE SEEN /LPF</td><td/></tr><tr><td ID="result7_attr17">NOTE</td><td/><td/><td ID="result7_attr17_notes"><p>This urine was analyzed for the presence of WBC,</p><p>RBC, bacteria, casts, and other formed elements.</p><p>Only those elements seen were reported.</p></td></tr><tr><td colspan="4"><span class="content_span">CBC (INCLUDES DIFF/PLT) (6399)</span><br/>Reviewed date:[REDACTED] 08:01:01 AM<br/>Interpretation:<br/>Performing Lab:TP, Quest Diagnostics-Tampa
[REDACTED][REDACTED][REDACTED] [REDACTED] MD<br/>Notes/Report:<br/>FASTING:YES<br/>FASTING: YES</td></tr><tr><td ID="result8_attr1">WHITE BLOOD CELL COUNT</td><td>5.2</td><td>3.8-10.8 Thousand/uL</td><td/></tr><tr><td ID="result8_attr2">RED BLOOD CELL COUNT</td><td>4.68</td><td>3.80-5.10 Million/uL</td><td/></tr><tr><td ID="result8_attr3">HEMOGLOBIN</td><td>13.9</td><td>11.7-15.5 g/dL</td><td/></tr><tr><td ID="result8_attr4">HEMATOCRIT</td><td>40.4</td><td>35.0-45.0 %</td><td/></tr><tr><td ID="result8_attr5">MCV</td><td>86.3</td><td>80.0-100.0 fL</td><td/></tr><tr><td ID="result8_attr6">MCH</td><td>29.7</td><td>27.0-33.0 pg</td><td/></tr><tr><td ID="result8_attr7">MCHC</td><td>34.4</td><td>32.0-36.0 g/dL</td><td/></tr><tr><td ID="result8_attr8">RDW</td><td>12.6</td><td>11.0-15.0 %</td><td/></tr><tr><td ID="result8_attr9">PLATELET COUNT</td><td>313</td><td>140-400 Thousand/uL</td><td/></tr><tr><td ID="result8_attr10">MPV</td><td>9.3</td><td>7.5-12.5 fL</td><td/></tr><tr><td ID="result8_attr11">ABSOLUTE NEUTROPHILS</td><td>3474</td><td>1500-7800 cells/uL</td><td/></tr><tr><td ID="result8_attr12">ABSOLUTE LYMPHOCYTES</td><td>1082</td><td>850-3900 cells/uL</td><td/></tr><tr><td ID="result8_attr13">ABSOLUTE MONOCYTES</td><td>390</td><td>200-950 cells/uL</td><td/></tr><tr><td ID="result8_attr14">ABSOLUTE EOSINOPHILS</td><td>203</td><td>15-500 cells/uL</td><td/></tr><tr><td ID="result8_attr15">ABSOLUTE BASOPHILS</td><td>52</td><td>0-200 cells/uL</td><td/></tr><tr><td ID="result8_attr16">NEUTROPHILS</td><td>66.8</td><td/><td/></tr><tr><td ID="result8_attr17">LYMPHOCYTES</td><td>20.8</td><td/><td/></tr><tr><td ID="result8_attr18">MONOCYTES</td><td>7.5</td><td/><td/></tr><tr><td ID="result8_attr19">EOSINOPHILS</td><td>3.9</td><td/><td/></tr><tr><td ID="result8_attr20">BASOPHILS</td><td>1.0</td><td/><td/></tr><tr><td colspan="4"><span class="content_span">COMPREHENSIVE METABOLIC PANEL (10231)</span><br/>Reviewed date:[REDACTED] 08:01:01 AM<br/>Interpretation:<br/>Performing Lab:TP, Quest Diagnostics-[REDACTED]
[REDACTED][REDACTED][REDACTED] [REDACTED] MD<br/>Notes/Report:<br/>FASTING:YES<br/>FASTING: YES</td></tr><tr><td ID="result9_attr1">GLUCOSE</td><td>100</td><td>65-99 mg/dL</td><td ID="result9_attr1_notes"><p/><p>           Fasting reference interval</p><p>For someone without known diabetes, a glucose value</p><p>between 100 and 125 mg/dL is consistent with</p><p>prediabetes and should be confirmed with a</p><p>follow-up test.</p></td></tr><tr><td ID="result9_attr2">UREA NITROGEN (BUN)</td><td>15</td><td>7-25 mg/dL</td><td/></tr><tr><td ID="result9_attr3">CREATININE</td><td>0.65</td><td>0.60-1.00 mg/dL</td><td/></tr><tr><td ID="result9_attr4">EGFR</td><td>93</td><td>&gt; OR = 60 mL/min/1.73m2</td><td/></tr><tr><td ID="result9_attr5">BUN/CREATININE RATIO</td><td>SEE NOTE:</td><td>6-22 (calc)</td><td ID="result9_attr5_notes"><p>   Not Reported: BUN and Creatinine are within</p><p>   reference range.</p></td></tr><tr><td ID="result9_attr6">SODIUM</td><td>135</td><td>135-146 mmol/L</td><td/></tr><tr><td ID="result9_attr7">POTASSIUM</td><td>3.6</td><td>3.5-5.3 mmol/L</td><td/></tr><tr><td ID="result9_attr8">CHLORIDE</td><td>96</td><td>98-110 mmol/L</td><td/></tr><tr><td ID="result9_attr9">CARBON DIOXIDE</td><td>30</td><td>20-32 mmol/L</td><td/></tr><tr><td ID="result9_attr10">CALCIUM</td><td>9.9</td><td>8.6-10.4 mg/dL</td><td/></tr><tr><td ID="result9_attr11">PROTEIN, TOTAL</td><td>7.1</td><td>6.1-8.1 g/dL</td><td/></tr><tr><td ID="result9_attr12">ALBUMIN</td><td>4.7</td><td>3.6-5.1 g/dL</td><td/></tr><tr><td ID="result9_attr13">GLOBULIN</td><td>2.4</td><td>1.9-3.7 g/dL (calc)</td><td/></tr><tr><td ID="result9_attr14">ALBUMIN/GLOBULIN RATIO</td><td>2.0</td><td>1.0-2.5 (calc)</td><td/></tr><tr><td ID="result9_attr15">BILIRUBIN, TOTAL</td><td>0.5</td><td>0.2-1.2 mg/dL</td><td/></tr><tr><td ID="result9_attr16">ALKALINE PHOSPHATASE</td><td>55</td><td>37-153 U/L</td><td/></tr><tr><td ID="result9_attr17">AST</td><td>19</td><td>10-35 U/L</td><td/></tr><tr><td ID="result9_attr18">ALT</td><td>23</td><td>6-29 U/L</td><td/></tr><tr><td colspan="4"><span class="content_span">THYROID PANEL WITH TSH (7444)</span><br/>Reviewed date:[REDACTED] 08:00:40 AM<br/>Interpretation:<br/>Performing Lab:TP, Quest Diagnostics-[REDACTED]
[REDACTED][REDACTED][REDACTED] [REDACTED] MD<br/>Notes/Report:<br/>FASTING:YES<br/>FASTING: YES</td></tr><tr><td ID="result10_attr1">T3 UPTAKE</td><td>31</td><td>22-35 %</td><td/></tr><tr><td ID="result10_attr2">T4 (THYROXINE), TOTAL</td><td>7.7</td><td>5.1-11.9 mcg/dL</td><td/></tr><tr><td ID="result10_attr3">FREE T4 INDEX (T7)</td><td>2.4</td><td>1.4-3.8</td><td/></tr><tr><td ID="result10_attr4">TSH</td><td>1.97</td><td>0.40-4.50 mIU/L</td><td/></tr><tr><td colspan="4"><span class="content_span">LIPID PANEL, STANDARD (7600)</span><br/>Reviewed date:[REDACTED] 08:01:01 AM<br/>Interpretation:<br/>Performing Lab:TP, Quest Diagnostics-Tampa
[REDACTED][REDACTED][REDACTED] [REDACTED] MD<br/>Notes/Report:<br/>FASTING:YES<br/>FASTING: YES</td></tr><tr><td ID="result11_attr1">CHOLESTEROL, TOTAL</td><td>158</td><td>&lt;200 mg/dL</td><td/></tr><tr><td ID="result11_attr2">HDL CHOLESTEROL</td><td>56</td><td>&gt; OR = 50 mg/dL</td><td/></tr><tr><td ID="result11_attr3">TRIGLYCERIDES</td><td>176</td><td>&lt;150 mg/dL</td><td/></tr><tr><td ID="result11_attr4">LDL-CHOLESTEROL</td><td>75</td><td/><td ID="result11_attr4_notes"><p>Reference range: &lt;100</p><p>Desirable range &lt;100 mg/dL for primary prevention;</p><p>&lt;70 mg/dL for patients with CHD or diabetic patients</p><p>with &gt; or = 2 CHD risk factors.</p><p>LDL-C is now calculated using the [REDACTED]</p><p>calculation, which is a validated novel method providing</p><p>better accuracy than the Friedewald equation in the</p><p>estimation of LDL-C.</p><p>[REDACTED] et al. JAMA. 2013;310(19): [REDACTED]-[REDACTED]</p><p>(http://education.QuestDiagnostics.com/faq/FAQ164)</p></td></tr><tr><td ID="result11_attr5">CHOL/HDLC RATIO</td><td>2.8</td><td>&lt;5.0 (calc)</td><td/></tr><tr><td ID="result11_attr6">NON HDL CHOLESTEROL</td><td>102</td><td>&lt;130 mg/dL (calc)</td><td ID="result11_attr6_notes"><p>For patients with diabetes plus 1 major ASCVD risk</p><p>factor, treating to a non-HDL-C goal of &lt;100 mg/dL</p><p>(LDL-C of &lt;70 mg/dL) is considered a therapeutic</p><p>option.</p></td></tr></tbody></table></div><h3><a name="id3" href="#toc">Reason For Referral</a></h3><div><table width="100%" border="1"><tbody><tr><th>Reason</th><td>[REDACTED] left nasal sidewall </td></tr><tr><th>Diagnosis 1</th><td>Carcinoma in situ of other site of skin (D04.8)</td></tr><tr><th>Referral Organization</th><td>MCM Brooksville</td></tr><tr><th>Referring Provider First Name</th><td>Anurag</td></tr><tr><th>Referring Provider Last Name</th><td>Kumbham</td></tr><tr><th>Referring Provider Speciality</th><td>Internal Medicine</td></tr><tr><th>Referred Provider Specialty</th><td>Dermatology</td></tr><tr><th>Procedure 1</th><td>MOHS, 1 STAGE, H/N/HF/G (17311)</td></tr><tr><th>Procedure 2</th><td>MOHS ADDL STAGE (17312)</td></tr><tr><th>Procedure 3</th><td>MOHS SURG, ADDL BLOCK (17315)</td></tr><tr><th>Procedure 4</th><td>SKIN TISSUE REARRANGEMENT (14060)</td></tr><tr><th>Procedure 5</th><td>SKIN TISSUE REARRANGEMENT (14061)</td></tr><tr><th>Procedure 6</th><td>SKIN TISSUE REARRANGEMENT (14301)</td></tr><tr><th>Procedure 7</th><td>SKIN TISSUE REARRANGE ADD-ON (14302)</td></tr><tr><th>Procedure 8</th><td>SKIN FULL GRAFT (15260)</td></tr><tr><th>Procedure 9</th><td>SKIN FULL GRAFT ADD-ON (15261)</td></tr><tr><th>Procedure 10</th><td>EAR CARTILAGE GRAFT (21235)</td></tr><tr><th>Procedure 11</th><td>REPAIR OF WOUND OR LESION (13151)</td></tr><tr><th>Procedure 12</th><td>REPAIR OF WOUND OR LESION (13152)</td></tr><tr><th>Procedure 13</th><td>REPAIR WOUND/LESION ADD-ON (13153)</td></tr><tr><th>General Notes</th><td>[REDACTED] [REDACTED] 03:39:01 PM &gt;submitted to ins</td></tr><tr><th>Referral Priority</th><td>Routine</td></tr><tr><th>Referral Appointment Date</th><td>[REDACTED]</td></tr></tbody></table><table width="100%" border="1"><tbody><tr><th>Reason</th><td>rehab therapy works - pt - 14 visits</td></tr><tr><th>Diagnosis 1</th><td>Low back pain, unspecified (M54.50)</td></tr><tr><th>Referral Organization</th><td>MCM Brooksville</td></tr><tr><th>Referring Provider First Name</th><td>Anurag</td></tr><tr><th>Referring Provider Last Name</th><td>Kumbham</td></tr><tr><th>Referring Provider Speciality</th><td>Internal Medicine</td></tr><tr><th>Referred Provider</th><td>Rehab Therapy Works</td></tr><tr><th>Referred Provider Specialty</th><td>Physical Therapist</td></tr><tr><th>Procedure 1</th><td>PT EVAL LOW COMPLEX 20 MIN (97161)</td></tr><tr><th>Procedure 2</th><td>PT EVAL MOD COMPLEX 30 MIN (97162)</td></tr><tr><th>Procedure 3</th><td>PT EVAL HIGH COMPLEX 45 MIN (97163)</td></tr><tr><th>Procedure 4</th><td>PT RE-EVAL EST PLAN CARE (97164)</td></tr><tr><th>Procedure 5</th><td>THERAPEUTIC EXERCISES (97110)</td></tr><tr><th>General Notes</th><td>[REDACTED] [REDACTED] 04:33:05 PM &gt;faxed [REDACTED]</td></tr><tr><th>Referral Priority</th><td>Routine</td></tr></tbody></table><table width="100%" border="1"><tbody><tr><th>Reason</th><td>Rehab Therapy Works - re-eval plan of care - 1 visit</td></tr><tr><th>Diagnosis 1</th><td>Acute bilateral low back pain without sciatica (M54.50)</td></tr><tr><th>Referral Organization</th><td>MCM Brooksville</td></tr><tr><th>Referring Provider First Name</th><td>Anurag</td></tr><tr><th>Referring Provider Last Name</th><td>Kumbham</td></tr><tr><th>Referring Provider Speciality</th><td>Internal Medicine</td></tr><tr><th>Referred Provider</th><td>Rehab Therapy Works</td></tr><tr><th>Referred Provider Specialty</th><td>Physical Therapist</td></tr><tr><th>Procedure 1</th><td>PT RE-EVAL EST PLAN CARE (97164)</td></tr><tr><th>General Notes</th><td>[REDACTED] [REDACTED] 03:07:06 PM &gt;FAXED [REDACTED]</td></tr><tr><th>Referral Priority</th><td>Routine</td></tr></tbody></table><table width="100%" border="1"><tbody><tr><th>Reason</th><td>DME - CMO for heel and arch pain - [REDACTED]</td></tr><tr><th>Diagnosis 1</th><td>Bilateral plantar fasciitis (M72.2)</td></tr><tr><th>Referral Organization</th><td>MCM Brooksville</td></tr><tr><th>Referring Provider First Name</th><td>Anurag</td></tr><tr><th>Referring Provider Last Name</th><td>Kumbham</td></tr><tr><th>Referring Provider Speciality</th><td>Internal Medicine</td></tr><tr><th>Referred Provider</th><td>[REDACTED]</td></tr><tr><th>Referred Provider Specialty</th><td>Podiatry</td></tr><tr><th>Procedure 1</th><td>FT INSRT MOLD UCB TYPE BERKLY SHELL (L3000)</td></tr><tr><th>Referral Priority</th><td>Routine</td></tr></tbody></table></div><h3><a name="id4" href="#toc">Medications</a></h3><div><table width="100%" border="1"><thead><tr><th>Medication</th><th>SIG (Take, Route, Frequency, Duration)</th><th>Notes</th><th>Start Date</th><th>End Date</th><th>Status</th></tr></thead><tbody><tr><td ID="medication1">predniSONE 5 MG (21)</td><td ID="instruction1">as directed Orally Once a day for 5 days</td><td/><td>[REDACTED]</td><td/><td>Not-Taking</td></tr><tr><td ID="medication2">Memantine HCl 5 MG</td><td ID="instruction2">1 tablet Orally Once a day for 90 days</td><td/><td>[REDACTED]</td><td/><td>Active</td></tr><tr><td ID="medication3">Albuterol Sulfate HFA 108 (90 Base) MCG/ACT</td><td ID="instruction3">2 puff as needed Inhalation every 4 hrs for 30 days</td><td/><td>[REDACTED]</td><td/><td>Not-Taking</td></tr><tr><td ID="medication4">Plavix 75 MG</td><td ID="instruction4">1 tablet Orally Once a day</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication5">Rosuvastatin Calcium 20 MG</td><td ID="instruction5">Take 1 tablet by mouth once daily for 90</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication6">Gabapentin 100 MG</td><td ID="instruction6">TAKE 1 CAPSULE BY MOUTH THREE TIMES DAILY for 90</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication7">Nitrofurantoin Monohyd Macro 100 MG</td><td ID="instruction7">1 capsule with food Orally every 12 hrs for 7 days</td><td/><td>[REDACTED]</td><td/><td>Not-Taking</td></tr><tr><td ID="medication8">Zithromax Z-Pak 250 MG</td><td ID="instruction8">as directed Orally Once a day for 5 days</td><td/><td>[REDACTED]</td><td/><td>Not-Taking</td></tr><tr><td ID="medication9">Losartan Potassium-HCTZ 50-12.5 MG</td><td ID="instruction9">1 tablet Orally Once a day for 90 days</td><td/><td>[REDACTED]</td><td/><td>Active</td></tr><tr><td ID="medication10">Amoxicillin-Pot Clavulanate 875-125 MG</td><td ID="instruction10">1 tablet Orally every 12 hrs for 10 days</td><td/><td>[REDACTED]</td><td/><td>Not-Taking</td></tr><tr><td ID="medication11">hydroCHLOROthiazide 12.5 MG</td><td ID="instruction11">1 tablet in the morning Orally Once a day for 90 days</td><td/><td>[REDACTED]</td><td/><td>Active</td></tr></tbody></table></div><h3><a name="id5" href="#toc">Immunizations</a></h3><div><table width="100%" border="1"><thead><tr><th>Vaccine</th><th>Route</th><th>Administration Date</th><th>Status</th><th>Comments</th></tr></thead><tbody><tr><td ID="immunization1">FLUAD HD - MCR</td><td>IM Intramuscular</td><td>[REDACTED]</td><td>Administered</td><td/></tr><tr><td ID="immunization2">Flucelvax Quadrivalent</td><td>IM Intramuscular</td><td>[REDACTED]</td><td>Administered</td><td/></tr><tr><td ID="immunization3">Pneumococcal polysaccharide PPV23</td><td>Unknown</td><td>[REDACTED]</td><td>Administered</td><td ID="immunization3notes">  Immunization Given by from source eCW:: </td></tr><tr><td ID="immunization4">Shingrix 0.5 mL</td><td>Unknown</td><td>[REDACTED]</td><td>Administered</td><td/></tr><tr><td ID="immunization5">Shingrix 0.5 mL</td><td>Unknown</td><td>[REDACTED]</td><td>Administered</td><td/></tr></tbody></table></div><h3><a name="id6" href="#toc">Social History</a></h3><div><span class="content_span">Tobacco Use:</span><table width="100%" border="1"><thead><tr><th>Social History Observation</th><th>Description</th><th>Date</th></tr></thead><tbody><tr><td ID="smokingStatus1">Details (start date - stop date)</td><td>Never Smoker</td><td>NA - NA</td></tr></tbody></table><span class="content_span">Sex Assigned At Birth:</span><table width="100%" border="1"><thead><tr><th>Social History Observation</th><th>Description</th></tr></thead><tbody><tr><td ID="BirthSexInfo">Sex Assigned At Birth</td><td>Female</td></tr></tbody></table><span class="content_span">Tobacco Use/Smoking</span><table width="100%" border="1"><thead><tr><th>Question</th><th>Answer</th><th>Notes</th></tr></thead><tbody><tr><td>Tobacco use:</td><td>nonsmoker</td><td/></tr></tbody></table><span class="content_span">Alcohol Screen (Audit-C)</span><table width="100%" border="1"><thead><tr><th>Question</th><th>Answer</th><th>Notes</th></tr></thead><tbody><tr><td>Did you have a drink containing alcohol in the past year?</td><td>No</td><td/></tr><tr><td>Points</td><td>0</td><td/></tr><tr><td>Interpretation</td><td>Negative</td><td/></tr></tbody></table><span class="content_span">AUDIT-C (Standard)</span><table width="100%" border="1"><thead><tr><th>Question</th><th>Answer</th><th>Notes</th></tr></thead><tbody><tr><td>Did you have a drink containing alcohol in the past year?</td><td>No</td><td/></tr><tr><td>Points</td><td>0</td><td/></tr><tr><td>Interpretation</td><td>Negative</td><td/></tr></tbody></table><span class="content_span">Tobacco Control (Standard)</span><table ID="socialhistorynotes" width="100%" border="1"><thead><tr><th>Question</th><th>Answer</th><th>Notes</th></tr></thead><tbody><tr><td>Tobacco use:</td><td>Nonsmoker</td><td/></tr></tbody></table></div><h3><a name="id7" href="#toc">Problems</a></h3><div><table width="100%" border="1"><thead><tr><th>Problem Type</th><th>SNOMED Code</th><th>ICD Code</th><th>Onset Dates</th><th>Problem Status</th><th>W/U Status</th><th>Risk</th><th>Notes</th></tr></thead><tbody><tr><td>Problem</td><td>Non-thrombocytopenic purpura (234493006)</td><td ID="Problem1">Other nonthrombocytopenic purpura (D69.2)</td><td/><td>Active</td><td>confirmed</td><td/><td/></tr><tr><td>Problem</td><td>193186008</td><td ID="Problem2">Polyneuropathy in diseases classified elsewhere (G63)</td><td/><td>Active</td><td>confirmed</td><td/><td/></tr><tr><td>Problem</td><td>82423001</td><td ID="Problem3">Other chronic pain (G89.29)</td><td/><td>Active</td><td>confirmed</td><td/><td/></tr><tr><td>Problem</td><td>213134006</td><td ID="Problem4">Pain due to internal orthopedic prosthetic devices, implants and grafts, initial encounter (T84.84XA)</td><td/><td>Active</td><td>confirmed</td><td/><td/></tr><tr><td>Problem</td><td>267434003</td><td ID="Problem5">Mixed hyperlipidemia (E78.2)</td><td/><td>Active</td><td>confirmed</td><td/><td/></tr><tr><td>Problem</td><td>162864005</td><td ID="Problem6">Body mass index [BMI] 33.0-33.9, adult (Z68.33)</td><td/><td>Active</td><td>confirmed</td><td/><td/></tr><tr><td>Problem</td><td>59621000</td><td ID="Problem7">Primary hypertension (I10)</td><td/><td>Active</td><td>confirmed</td><td/><td/></tr><tr><td>Problem</td><td>77075001</td><td ID="Problem8">Primary open angle glaucoma ([REDACTED]) of both eyes, mild stage (H40.1131)</td><td/><td>Active</td><td>confirmed</td><td/><td/></tr><tr><td>Problem</td><td>700132008</td><td ID="Problem9">S/P VP shunt (Z98.2)</td><td/><td>Active</td><td>confirmed</td><td/><td/></tr><tr><td>Problem</td><td>427749007</td><td ID="Problem10">History of bilateral knee replacement (Z96.653)</td><td/><td>Active</td><td>confirmed</td><td/><td/></tr><tr><td>Problem</td><td>15662003</td><td ID="Problem11">Senile dementia (F03.90)</td><td/><td>Active</td><td>confirmed</td><td/><td/></tr></tbody></table></div><h3><a name="id8" href="#toc">Vital Signs</a></h3><div><table width="100%" border="1"><tbody><tr><th ID="vital1">Heart Rate</th><td>70 /min</td><td>[REDACTED]</td><td/></tr><tr><th ID="vital2">Temperature</th><td>97.6 degrees Fahrenheit</td><td>[REDACTED]</td><td/></tr><tr><th ID="vital3">Blood pressure diastolic</th><td>79 mm Hg</td><td>[REDACTED]</td><td/></tr><tr><th ID="vital4">Oximetry</th><td>97 %</td><td>[REDACTED]</td><td/></tr><tr><th ID="vital5">Weight-kg</th><td>70.31 kg</td><td>[REDACTED]</td><td/></tr><tr><th ID="vital6">Height</th><td>62 in</td><td>[REDACTED]</td><td/></tr><tr><th ID="vital7">Blood pressure systolic</th><td>130 mm Hg</td><td>[REDACTED]</td><td/></tr><tr><th ID="vital8">Weight</th><td>155 lbs</td><td>[REDACTED]</td><td/></tr><tr><th ID="vital9">BMI</th><td>28.35 kg/m2</td><td>[REDACTED]</td><td/></tr></tbody></table></div><h3><a name="id9" href="#toc">Procedures</a></h3><div><span class="content_span">No Information</span></div><h3><a name="id10" href="#toc">Encounters</a></h3><div><table width="100%" border="1"><thead><tr><th>Encounter</th><th>Location</th><th>Date</th><th>Provider</th><th>Diagnosis</th></tr></thead><tbody><tr><td>MCM Brooksville</td><td>[REDACTED][REDACTED][REDACTED]</td><td>[REDACTED]</td><td>[REDACTED]</td><td/></tr><tr><td>MCM Brooksville</td><td>[REDACTED][REDACTED][REDACTED]</td><td>[REDACTED]</td><td>[REDACTED]</td><td/></tr><tr><td>MCM Brooksville</td><td>[REDACTED][REDACTED][REDACTED]</td><td>[REDACTED]</td><td>[REDACTED]</td><td/></tr><tr><td>MCM Brooksville</td><td>[REDACTED][REDACTED][REDACTED]</td><td>[REDACTED]</td><td>[REDACTED]</td><td>Acute cystitis without hematuria N30.00 ; COVID-19 U07.1 ; Mixed hyperlipidemia E78.2 and Primary hypertension I10</td></tr><tr><td>MCM Brooksville</td><td>[REDACTED][REDACTED][REDACTED]</td><td>[REDACTED]</td><td>[REDACTED]</td><td>Mixed hyperlipidemia E78.2 ; Primary hypertension I10 ; B12 deficiency E53.8 and Vitamin D deficiency E55.9</td></tr><tr><td>MCM Brooksville</td><td>[REDACTED][REDACTED][REDACTED]</td><td>[REDACTED]</td><td>[REDACTED]</td><td>Mixed hyperlipidemia E78.2 ; Primary hypertension I10 ; Polyneuropathy in diseases classified elsewhere G63 ; Pain due to internal orthopedic prosthetic devices, implants and grafts, initial encounter T84.84XA ; History of bilateral knee replacement Z96.653 ; IFG (impaired fasting glucose) R73.01 ; Body mass index [BMI] 33.0-33.9, adult Z68.33 ; Encounter for screening for osteoporosis Z13.820 ; Encounter for screening mammogram for malignant neoplasm of breast Z12.31 ; Primary open angle glaucoma ([REDACTED]) of both eyes, mild stage H40.1131 ; B12 deficiency E53.8 ; S/P VP shunt Z98.2 ; Other chronic pain G89.29 and Low back pain, unspecified M54.50</td></tr><tr><td>MCM Brooksville</td><td>[REDACTED][REDACTED][REDACTED]</td><td>[REDACTED]</td><td>[REDACTED]</td><td>MEMORY CHANGES R41.3 and S/P VP shunt Z98.2</td></tr><tr><td>MCM Brooksville</td><td>[REDACTED][REDACTED][REDACTED]</td><td>[REDACTED]</td><td>[REDACTED]</td><td>Mixed hyperlipidemia E78.2 ; Primary hypertension I10 ; Polyneuropathy in diseases classified elsewhere G63 ; Pain due to internal orthopedic prosthetic devices, implants and grafts, initial encounter T84.84XA ; History of bilateral knee replacement Z96.653 ; IFG (impaired fasting glucose) R73.01 ; Primary open angle glaucoma ([REDACTED]) of both eyes, mild stage H40.1131 ; B12 deficiency E53.8 ; S/P VP shunt Z98.2 ; Other chronic pain G89.29 ; Low back pain, unspecified M54.50 ; Senile dementia F03.90 ; Other nonthrombocytopenic purpura D69.2 ; Encounter for immunization Z23 and Left leg swelling M79.89</td></tr></tbody></table></div><h3><a name="id11" href="#toc">Medical Equipment</a></h3><div>No Information</div><h3><a name="id12" href="#toc">Assessments</a></h3><div><table width="100%" border="1"><thead><tr><th>Encounter Date</th><th>Diagnosis (ICD Code)</th><th>Assessment Notes</th><th>Treatment Notes</th><th>Treatment Clinical Notes</th></tr></thead><tbody><tr><td ID="ref1">[REDACTED]</td><td>Acute cystitis without hematuria (ICD-10 - N30.00)</td><td/><td>Request USG report from advanced imaging.</td><td/></tr><tr><td ID="ref2">[REDACTED]</td><td>COVID-19 (ICD-10 - U07.1)</td><td/><td/><td/></tr><tr><td ID="ref3">[REDACTED]</td><td>Mixed hyperlipidemia (ICD-10 - E78.2)</td><td/><td>stable LDL, continue crestor</td><td/></tr><tr><td ID="ref4">[REDACTED]</td><td>Primary hypertension (ICD-10 - I10)</td><td/><td><p>Stable</p><p>Continue to monitor</p></td><td/></tr><tr><td ID="ref5">[REDACTED]</td><td>Mixed hyperlipidemia (ICD-10 - E78.2)</td><td/><td>stable LDL, continue crestor</td><td/></tr><tr><td ID="ref6">[REDACTED]</td><td>Primary hypertension (ICD-10 - I10)</td><td/><td><p>Stable</p><p>Continue to monitor</p></td><td/></tr><tr><td ID="ref7">[REDACTED]</td><td>Mixed hyperlipidemia (ICD-10 - E78.2)</td><td/><td>stable LDL, continue crestor</td><td/></tr><tr><td ID="ref8">[REDACTED]</td><td>Primary hypertension (ICD-10 - I10)</td><td/><td><p>Stable</p><p>Continue to monitor</p><p>Taking losatan 50/12.5 and adding 12.5 HCTZ to make 50/50</p></td><td/></tr><tr><td ID="ref9">[REDACTED]</td><td>MEMORY CHANGES (ICD-10 - R41.3)</td><td/><td><p>Mini- cog 4/5</p><p>CT ordered</p></td><td/></tr><tr><td ID="ref10">[REDACTED]</td><td>S/P VP shunt (ICD-10 - Z98.2)</td><td/><td/><td/></tr><tr><td ID="ref11">[REDACTED]</td><td>Polyneuropathy in diseases classified elsewhere (ICD-10 - G63)</td><td/><td>Stable with gabapentin</td><td/></tr><tr><td ID="ref12">[REDACTED]</td><td>B12 deficiency (ICD-10 - E53.8)</td><td/><td/><td/></tr><tr><td ID="ref13">[REDACTED]</td><td>Polyneuropathy in diseases classified elsewhere (ICD-10 - G63)</td><td/><td>Stable with gabapentin</td><td/></tr><tr><td ID="ref14">[REDACTED]</td><td>Mixed hyperlipidemia (ICD-10 - E78.2)</td><td/><td>stable LDL, continue crestor</td><td/></tr><tr><td ID="ref15">[REDACTED]</td><td>Vitamin D deficiency (ICD-10 - E55.9)</td><td/><td/><td/></tr><tr><td ID="ref16">[REDACTED]</td><td>Primary hypertension (ICD-10 - I10)</td><td/><td><p>Stable</p><p>Continue to monitor</p></td><td/></tr><tr><td ID="ref17">[REDACTED]</td><td>Pain due to internal orthopedic prosthetic devices, implants and grafts, initial encounter (ICD-10 - T84.84XA)</td><td/><td>OTC meds</td><td/></tr><tr><td ID="ref18">[REDACTED]</td><td>Pain due to internal orthopedic prosthetic devices, implants and grafts, initial encounter (ICD-10 - T84.84XA)</td><td/><td>OTC meds</td><td/></tr><tr><td ID="ref19">[REDACTED]</td><td>History of bilateral knee replacement (ICD-10 - Z96.653)</td><td/><td>Stable</td><td/></tr><tr><td ID="ref20">[REDACTED]</td><td>History of bilateral knee replacement (ICD-10 - Z96.653)</td><td/><td>Stable</td><td/></tr><tr><td ID="ref21">[REDACTED]</td><td>IFG (impaired fasting glucose) (ICD-10 - R73.01)</td><td/><td>Check A1c</td><td/></tr><tr><td ID="ref22">[REDACTED]</td><td>IFG (impaired fasting glucose) (ICD-10 - R73.01)</td><td/><td>Check A1c</td><td/></tr><tr><td ID="ref23">[REDACTED]</td><td>Body mass index [BMI] 33.0-33.9, adult (ICD-10 - Z68.33)</td><td/><td>Diet and exercise</td><td/></tr><tr><td ID="ref24">[REDACTED]</td><td>Primary open angle glaucoma ([REDACTED]) of both eyes, mild stage (ICD-10 - H40.1131)</td><td/><td>Mild</td><td/></tr><tr><td ID="ref25">[REDACTED]</td><td>Encounter for screening for osteoporosis (ICD-10 - Z13.820)</td><td/><td>Dexa</td><td/></tr><tr><td ID="ref26">[REDACTED]</td><td>B12 deficiency (ICD-10 - E53.8)</td><td/><td>OTC replacement</td><td/></tr><tr><td ID="ref27">[REDACTED]</td><td>S/P VP shunt (ICD-10 - Z98.2)</td><td/><td>stable</td><td/></tr><tr><td ID="ref28">[REDACTED]</td><td>Encounter for screening mammogram for malignant neoplasm of breast (ICD-10 - Z12.31)</td><td/><td>Mammogram</td><td/></tr><tr><td ID="ref29">[REDACTED]</td><td>Other chronic pain (ICD-10 - G89.29)</td><td/><td>C</td><td/></tr><tr><td ID="ref30">[REDACTED]</td><td>Primary open angle glaucoma ([REDACTED]) of both eyes, mild stage (ICD-10 - H40.1131)</td><td/><td>Mild</td><td/></tr><tr><td ID="ref31">[REDACTED]</td><td>B12 deficiency (ICD-10 - E53.8)</td><td/><td>OTC replacement</td><td/></tr><tr><td ID="ref32">[REDACTED]</td><td>Low back pain, unspecified (ICD-10 - M54.50)</td><td/><td>otc meds</td><td/></tr><tr><td ID="ref33">[REDACTED]</td><td>S/P VP shunt (ICD-10 - Z98.2)</td><td/><td/><td/></tr><tr><td ID="ref34">[REDACTED]</td><td>Senile dementia (ICD-10 - F03.90)</td><td/><td>[REDACTED] Mini-cog 4/5</td><td/></tr><tr><td ID="ref35">[REDACTED]</td><td>Other nonthrombocytopenic purpura (ICD-10 - D69.2)</td><td/><td>skin care discussed</td><td/></tr><tr><td ID="ref36">[REDACTED]</td><td>Other chronic pain (ICD-10 - G89.29)</td><td/><td/><td/></tr><tr><td ID="ref37">[REDACTED]</td><td>Low back pain, unspecified (ICD-10 - M54.50)</td><td/><td/><td/></tr><tr><td ID="ref38">[REDACTED]</td><td>Encounter for immunization (ICD-10 - Z23)</td><td/><td/><td/></tr><tr><td ID="ref39">[REDACTED]</td><td>Left leg swelling (ICD-10 - M79.89)</td><td/><td/><td/></tr></tbody></table></div><h3><a name="id13" href="#toc">Plan Of Treatment</a></h3><div><span class="content_span">Future Test</span><table width="100%" border="1"><thead><tr><th>Test Name</th><th>Order Date</th></tr></thead><tbody><tr><td ID="futureTest1">Ultrasound : Abdomen and Pelvis (76700/76856)</td><td>[REDACTED]</td></tr><tr><td ID="futureTest2">DEXA (77080/77081)</td><td>[REDACTED]</td></tr><tr><td ID="futureTest3">X ray : L Spine x 2 view (72100)</td><td>[REDACTED]</td></tr><tr><td ID="futureTest4">Mammogram, Bilateral Screening (77067)</td><td>[REDACTED]</td></tr><tr><td ID="futureTest5">CT Scan : Brain</td><td>[REDACTED]</td></tr><tr><td ID="futureTest6">CBC With Differential/Platelet-005009</td><td>[REDACTED]</td></tr><tr><td ID="futureTest7">Lipid Panel-303756</td><td>[REDACTED]</td></tr><tr><td ID="futureTest8">CMP14+eGFR-334943</td><td>[REDACTED]</td></tr><tr><td ID="futureTest9">Ultrasound : Venous Lower Extremity, Left (93971)</td><td>[REDACTED]</td></tr></tbody></table><span class="content_span">Next Appt</span><table width="100%" border="1"><thead><tr><th>Details</th></tr></thead><tbody><tr><td ID="futureAppt1">Provider Name:[REDACTED], [REDACTED] 09:00:00 AM, [REDACTED][REDACTED][REDACTED], [REDACTED]</td></tr></tbody></table></div><h3><a name="id14" href="#toc">Goals Section</a></h3><div>No Information</div><h3><a name="id15" href="#toc">Health Concerns</a></h3><div>No Information</div><h3><a name="id16" href="#toc">Insurance Providers</a></h3><div><table width="100%" border="1"><thead><tr><th>Payer Name</th><th>Payer Address</th><th>Payer Phone</th><th>Subscriber Number</th><th>Group Number</th><th>Insured Name</th><th>Patient Relationship to Insured</th><th>Coverage Start Date</th><th>Coverage End Date</th></tr></thead><tbody><tr><td>Optimum HMO</td><td>[REDACTED]</td><td>[REDACTED]</td><td>T9907802501</td><td/><td>[REDACTED]</td><td>Self - patient is the insured</td><td>[REDACTED]</td><td/></tr></tbody></table></div><h3><a name="id17" href="#toc">Medical (General) History</a></h3><div><span class="content_span">Medical History</span><table width="100%" border="1"><thead><tr><th>History</th><th>ICD Code</th></tr></thead><tbody><tr><td>OA, Vit D Deficency</td><td/></tr><tr><td>HLD, HTN, Obesity, IFG</td><td/></tr><tr><td>TIA  hx</td><td/></tr><tr><td>[REDACTED]- no drops</td><td/></tr><tr><td>Left Heel Plantar Fasciitis</td><td/></tr></tbody></table><span class="content_span">Surgical History</span><table width="100%" border="1"><thead><tr><th>Surgery</th><th>Date(Month/Year)</th></tr></thead><tbody><tr><td>Appendectomy</td><td>1957</td></tr><tr><td>Hydrocephalus s/p shunt</td><td>2003</td></tr><tr><td>skin cancer removed from left side of nose/cheek</td><td>1/2024</td></tr><tr><td>Left and Right Knee replacement</td><td>2018</td></tr></tbody></table><span class="content_span">Hospitalization History</span><table width="100%" border="1"><thead><tr><th>Reason</th><th>Date(Month/Year)</th></tr></thead><tbody><tr><td>TIA</td><td/></tr><tr><td>UTI - ER</td><td>8/21-22/2023</td></tr></tbody></table></div><br/><br/>
</body></html>